Real estate Web sites Zillow and Trulia have crafted a clever deal to send their high-flying share prices to even greater heights.» Read More
CNBC's Bob Pisani and Art Cashin, of UBS, discuss the pop in crude and talk of European sanctions.
Bespoke says 68 percent of the S&P 500 stocks are trading above their 50-day moving averages, and questions whether these stocks are getting ahead of themselves. CNBC's Jim Cramer takes a closer look at individual stocks.
Jim Cramer explains what to watch ahead of the open, including Visa.
Insiders at Zillow and Trulia sold shares aggressively before news of a potential merger broke Thursday, according to filings.
Fashion house Michael Kors has a lot of fans out there. One that would have a tough time getting by without it: watchmaker Fossil Group.
Dunkin Brands' quarter did not impress Wall Street, reports CNBC's Dominic Chu.
CNBC's Meg Tirrell crunches the numbers to figure out the cost to the U.S. economy when companies relocate overseas.
Fast Money trader Mike Murphy made a bold call on Facebook back in December and thinks the stock can go a lot higher.
CNBC's Bob Pisani and Art Cashin, of UBS, discuss new highs in the S&P 500, the crashed Air Algerie flight and new home sales data.
Jim Cramer explains what to watch ahead of the open, including a bounce for Gilead Sciences.
Former U.S. Army Staff Sergeant Ryan Pitts is a recipient of the Medal of Honor for his actions in Iraq and Afghanistan. Sgt. Pitts speaks to CNBC's "Closing Bell" about his experience with Veterans Affairs, and receiving the medal.
Former U.S. Army Staff Sergeant Ryan Pitts apparently doesn't know his own strength. The Medal of Honor recipient rang the closing bell at the NYSE a bit too hard Wednesday -- he ended up breaking the gavel.
CNBC's Bob Pisani and Art Cashin, of UBS, discuss the floundering market. Traders are looking to see if there's another geopolitical shoe to fall.
Results of a clinical trial of a breast cancer drug could make this company a takeover target, too, says CNBC's Jim Cramer.
Jim Cramer explains what to watch ahead of the open, including Puma Biotechnology. Cramer says the stock could quadruple due to the results of a new drug trial.
Harley-Davidson may be one of America's strongest brands, but the shares could be in for another rout.
The reality is it's had a huge run, says Rich Greenfield, BTIG, weighing in on whether the company can sustain its current growth.
CNBC's Dominic Chu has the latest details on the departure of BATS President William O'Brien.
Fast Money trader Stephanie Link provides her real-time trades in the consumer space.
CNBC's Bob Pisani and Art Cashin, of UBS, discuss easing tensions in Ukraine, the move in oil, and the rally higher in the S&P 500.